Linaclotide
Linaclotide[edit | edit source]
Linaclotide (marketed as Linzess) is a guanylate cyclase-C agonist medication primarily employed for the management of chronic constipation and irritable bowel syndrome (IBS).
Overview[edit | edit source]
Linaclotide is a synthetic 14 amino acid peptide that acts as an agonist of the guanylate cyclase C receptors in the intestine, facilitating improved bowel movements and relief from symptoms associated with chronic constipation and IBS.
Indications[edit | edit source]
Linzess is indicated in adults for the treatment of:
- irritable bowel syndrome with constipation (IBS-C).
- Chronic idiopathic constipation (CIC), where the cause of the constipation is unidentified.
Mechanism of Action[edit | edit source]
Linaclotide's therapeutic action is based on its interaction with guanylate cyclase C receptors in the intestine:
- The agonistic action on this receptor escalates cyclic guanosine monophosphate levels, triggering the secretion of chloride and bicarbonate into the intestinal lumen. This, in turn, boosts fluid secretion, fostering intestinal transit.
- Linaclotide predominantly acts on the luminal side of enterocytes in the upper intestine, with minimal absorption into the bloodstream.
- Clinical trials have underscored its efficacy in increasing spontaneous bowel movements, refining stool consistency, and alleviating symptoms linked to chronic constipation and IBS.
Contraindications[edit | edit source]
Linaclotide is contraindicated in:
- Infants and toddlers below 2 years due to potential severe dehydration risks.
- Patients with identified or suspected mechanical gastrointestinal obstruction.
Drug Interactions[edit | edit source]
As of current knowledge, no formal drug interaction studies have been undertaken with Linzess.
FDA Approval[edit | edit source]
The FDA greenlit linaclotide for usage in the U.S. in 2012, marking its approval for treating IBS with constipation and idiopathic chronic constipation.
Dosage and Administration[edit | edit source]
IBS with Constipation[edit | edit source]
- Recommended dose: 290 mcg orally once daily.
Chronic Idiopathic Constipation[edit | edit source]
- Recommended dose: 145 mcg orally once daily. Depending on individual tolerance, a 72 mcg daily dose might be preferable.
General guidelines:
- Administer Linzess as prescribed by a healthcare provider.
- It should be taken on an empty stomach, roughly 30 minutes prior to the day's first meal.
- In case a dose is skipped, the next dose should be taken as scheduled without doubling up.
- Linzess capsules must be consumed whole and not be crushed or chewed.
- For adults who find swallowing the capsules challenging, it's permissible to sprinkle the beads over applesauce or mix with bottled water before ingestion.
- The compatibility of Linzess with other foods or liquids remains unverified.
Available Forms and Branding[edit | edit source]
Linaclotide is available in the following dosages as capsules:
- 72 mcg
- 145 mcg
- 290 mcg
Branding:
Side Effects[edit | edit source]
Common side effects:
- Gas formation
- Abdominal discomfort or pain
- Abdominal swelling or a sensation of fullness or pressure (distention)
Serious side effects:
Precautions[edit | edit source]
- Should not be administered to children below 2 years of age.
- Diarrhea is a commonly reported side effect in Linzess users. If severe diarrhea is encountered, the drug should be discontinued and the patient should be rehydrated.
Overdose[edit | edit source]
Symptoms suggestive of an overdose predominantly include:
- Severe diarrhea
Pregnancy[edit | edit source]
Data regarding Linzess's safety during pregnancy is currently insufficient to deduce any association with major birth defects or miscarriage risks.
Pediatric Use[edit | edit source]
Linzess is not advised for children under 2 years. Its safety and efficacy in those under 18 years remain inconclusive.
Ingredients[edit | edit source]
Active ingredient:
- Linaclotide
Inactive ingredients for 145 mcg and 290 mcg capsules:
- Calcium chloride dihydrate, hypromellose, L-leucine, and microcrystalline cellulose. Capsule's composition: gelatin and titanium dioxide.
Inactive ingredients for 72 mcg capsules:
- Calcium chloride dihydrate, L-histidine, microcrystalline cellulose, polyvinyl alcohol, and talc. Capsule's composition: gelatin and titanium dioxide.
Manufacturers and Distributors[edit | edit source]
Brand: Linzess® is a trademark of Ironwood Pharmaceuticals, Inc.
- Distributed by: Allergan USA, Inc., Madison, NJ
- Promoted by: Allergan USA, Inc., Madison, NJ and Ironwood Pharmaceuticals, Inc., Boston, MA
Storage and Disposal[edit | edit source]
- Store Linzess within a temperature range of 68°F to 77°F (20°C to 25°C).
- Retain the medicine in its original bottle, which comes with a desiccant packet to keep the medication dry.
- The bottle should be securely closed and stored in a dry setting.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen